N4 Pharma PLC (LON:N4P)
0.68p-0.74%
Spriggl Score: Weak— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Credentialed CEO pivots RNA platform; late 2026 cash expiry forces binary deal or dilution risk.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About N4 Pharma PLC
N4 Pharma Plc, a specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom. It develops Nuvec, a silica nanoparticle delivery system, which has an irregular…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £4.0M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on N4 Pharma PLC and 1,600+ UK and US stocks.
Start free